Medical Store Opening Made Easy In UP

Lucknow:  While granting a license to open a pharmaceutical company and sell medicines, entrepreneurs will no longer be subjected to rules like size of the firm, investment, domestic or foreign investor and business risk like other businesses.

Due to its inclusion in Invest UP’s Business Reform Action Plan (BRAP)-2024, entrepreneurs are facing difficulties in getting licenses. In such a situation, the Food Safety and Drug Administration Department has written a letter demanding exemption from this.

While granting license for setting up a pharmaceutical company or for sale of medicines under the Drug and Cosmetic Act, only the storage capacity as per standards, facility to keep medicines at low temperature and registration of pharmacist are considered.

According to BRAP-2024 of Invest UP, the Food Safety and Drug Administration Department has already made arrangements for granting and monitoring licenses through an online portal. There is also a system to deposit fees online for the license and to see with which officer the file is pending or everything online.

In such a situation, Principal Secretary, Food Safety and Drug Administration P. Guruprasad sent a letter to the Chief Executive Officer of Invest UP demanding exemption from rules like size of firm etc. under BRAP, because there is no provision for this in the Drug and Cosmetic Act, hence it cannot be implemented. At present, after getting the exemption, the drug entrepreneurs will get a lot of relief.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?